Welcome to LookChem.com Sign In|Join Free
  • or
2,4-Dichloro-7-iodoquinazoline is a heterocyclic aromatic compound characterized by a quinazoline ring structure, with the molecular formula C9H5Cl2IN2. It features two chlorine atoms and one iodine atom, making it a unique chemical entity with potential applications in various scientific fields.

959237-34-4

Post Buying Request

959237-34-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

959237-34-4 Usage

Uses

Used in Pharmaceutical Industry:
2,4-Dichloro-7-iodoquinazoline is utilized as a building block for the synthesis of various biologically active compounds, contributing to the development of new drugs with potential therapeutic benefits.
Used in Organic Chemistry and Materials Science Research:
2,4-Dichloro-7-iodoquinazoline serves as a valuable research tool, aiding scientists in understanding the properties and behaviors of similar chemical structures, thus advancing the fields of organic chemistry and materials science.
Used in Agricultural Applications:
2,4-Dichloro-7-iodoquinazoline has been investigated for its pesticidal properties, suggesting its potential use in agriculture to develop new and effective pest control solutions.

Check Digit Verification of cas no

The CAS Registry Mumber 959237-34-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,2,3 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 959237-34:
(8*9)+(7*5)+(6*9)+(5*2)+(4*3)+(3*7)+(2*3)+(1*4)=214
214 % 10 = 4
So 959237-34-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H3Cl2IN2/c9-7-5-2-1-4(11)3-6(5)12-8(10)13-7/h1-3H

959237-34-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Dichloro-7-iodoquinazoline

1.2 Other means of identification

Product number -
Other names 2,4,5-TRIFLUOROPHENYLACETIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:959237-34-4 SDS

959237-34-4Downstream Products

959237-34-4Relevant academic research and scientific papers

Design and synthesis of novel diaminoquinazolines with in vivo efficacy for β-catenin/t-cell transcriptional factor 4 pathway inhibition

Dehnhardt, Christoph M.,Venkatesan, Aranapakam M.,Chen, Zecheng,Ayral-Kaloustian, Semiramis,Dos Santos, Osvaldo Dos,Delos Santos, Efren,Curran, Kevin,Follettie, Max T.,Diesl, Veronica,Lucas, Judy,Geng, Yi,DeJoy, Susan Quinn,Petersen, Rosanne,Chaudhary, Inder,Brooijmans, Natasja,Mansour, Tarek S.,Arndt, Kim,Chen, Lei

experimental part, p. 897 - 910 (2010/07/05)

We are introducing a novel series of 2,4-diaminoquinazolines as β-catenin/Tcf4 inhibitors which were identified by ligand-based design. Here we elucidate the SAR of this series and explain how we were able to improve key molecular properties such as solubility and cLogP leading to compound 9. Analogue 9 exhibited better biological activity and improved physical and pharmacological properties relative to the HTS hit 49. Furthermore, 9 demonstrated good cell growth inhibition against several human colorectal cancer lines such as LoVo and HT29. In addition, treatment with compound 9 led to gene expression changes that overlapped significantly with the transcriptional profile resulting from the pathway inhibition by siRNA knockdown of β-catenin or Tcf4. Subsequently, 9 was tested for efficacy in a β-catenin/RKE-mouse xenograft, where it led to more then 50% decrease in tumor volume. 2009 American Chemical Society.

AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS

-

, (2008/12/07)

The present invention relates to amino-substituted quinazoline derivatives as inhibitors of β-catenin/tcf-4 pathway, which can be useful in the treatment of cancer; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 959237-34-4